Ropharma S.A. Logo

Ropharma S.A.

ISIN: ROIAFRACNOR4 | Ticker: RPH | LEI: 2138004ATSD4SVFAZ789
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Romania

About Ropharma S.A.

Company Description

ROPHARMA S.A. BRASOV is a pharmaceutical company resulted from the union of IassyFarm S.A. Iasi, Aesculap S.A. Targu Mures, Medica S.A. Bacau and Global Pharmaceuticals S.R.L. Brasov. The company operates based on an integrative business model:

- Distribution of pharmaceutical and parapharmaceutical products from warehouses of the 5 subsidiaries in Bucharest, Iasi, Bacau, Targu Mures and Cluj Napoca;

- Retailing using the company’s own pharmacy chain, counting 129 pharmacies spread all over the country in Iasi, Vaslui, Suceava, Botosani, Bacau, Neamt, Vrancea, Mures, Harghita, Brasov, Sibiu, Prahova, Alba, Cluj;

- Drugs, dietary supplements and formula manufacturing at S.C. Aesculap Prod S.R.L. (Targu Mures), S.C. Eurofarmaco S.A. (Chisinau) and S.C. Bioef S.R.L. (Dostat Alba).

- Medical services in Sfantul Constantin multidepartamental private practice hospital, Brasov.

Year founded

1952

Served area

Romania

Headquarters

Str. Iuliu Maniu, Nr. 55, Etaj 1, 500002 Brasov – Romania

Financial statements

Download as Excel
Line item in (ron) 02.01.2020 01.01.2021 02.01.2021 01.01.2022
Assets N/A 651,165,256.00 N/A 667,337,065.00
Noncurrent Assets N/A 291,475,647.00 N/A 302,243,086.00
Property Plant And Equipment N/A 185,166,403.00 N/A 187,772,664.00
Investment Property N/A 10,126,267.00 N/A 10,804,637.00
Goodwill N/A 11,613,659.00 N/A 11,167,579.00
Intangible Assets Other Than Goodwill N/A 21,581,490.00 N/A 22,718,590.00
Other Noncurrent Financial Assets N/A 146,709.00 N/A 1,001.00
Current Assets N/A 359,689,609.00 N/A 365,093,979.00
Cash and cash equivalents N/A 14,659,434.00 N/A 10,659,838.00
Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners N/A 9,963,160.00 N/A 0.00
Equity And Liabilities N/A 651,165,257.00 N/A 667,337,068.00
Equity 188,589,163.00 201,872,388.00 201,872,388.00 219,590,190.00
Issued Capital N/A 68,698,617.00 N/A 68,698,617.00
Retained Earnings N/A 49,346,634.00 N/A 56,734,828.00
Share Premium N/A 2,021,064.00 N/A 2,021,064.00
Treasury Shares N/A 147,635.00 N/A 133,513.00
Capital Reserve N/A 56,243,776.00 N/A 66,184,630.00
Noncontrolling Interests N/A 4,001,386.00 N/A 7,123,168.00
Liabilities N/A 449,292,869.00 N/A 447,746,878.00
Noncurrent Liabilities N/A 90,915,167.00 N/A 87,818,138.00
Deferred Tax Liabilities N/A 8,832,083.00 N/A 7,992,543.00
Longterm Borrowings N/A 35,720,904.00 N/A 27,338,589.00
Current Liabilities N/A 358,377,702.00 N/A 359,928,740.00
Current Provisions N/A 904,173.00 N/A 309,978.00
Current Government Grants N/A 266,604.00 N/A 249,561.00
Current Payables On Social Security And Taxes Other Than Income Tax N/A 4,229,778.00 N/A 4,345,512.00
Current Tax Liabilities Current N/A 3,550.00 N/A 541,453.00
Line item in (ron) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
Revenue 716,274,771.00 776,685,951.00
Other Income 94,619,284.00 113,586,935.00
Changes In Inventories Of Finished Goods And Work In Progress -93,182.00 385,599.00
Cost Of Merchandise Sold 621,772,625.00 682,780,330.00
Employee Benefits Expense 95,954,389.00 108,002,620.00
Depreciation Expense 22,690,307.00 23,151,046.00
Other Gains Losses -80,055.00 N/A
Profit Loss From Operating Activities 12,219,343.00 18,651,013.00
Finance Income 674,607.00 1,394,749.00
Finance Costs 6,256,482.00 6,516,296.00
Profit Loss Before Tax 6,637,468.00 13,529,466.00
Profit Loss From Continuing Operations 4,636,175.00 11,570,948.00
Profit (loss) 6,753,489.00 10,728,725.00
Profit Loss Attributable To Owners Of Parent 6,753,489.00 10,728,725.00
Profit Loss Attributable To Noncontrolling Interests -2,117,314.00 842,223.00
Line item in (ron) 01.01.2021 01.01.2022
Profit (loss) 6,753,489.00 10,728,725.00
Adjustments For Decrease Increase In Inventories 12,109,774.00 -15,483,150.00
Adjustments For Depreciation And Amortisation Expense 22,690,307.00 23,151,046.00
Adjustments For Losses Gains On Disposal Of Noncurrent Assets -29,620.00 -945,915.00
Cash Flows From Used In Operations -8,831,418.00 1,433,419.00
Interest Paid Classified As Operating Activities 3,262,996.00 3,221,056.00
Interest Received Classified As Operating Activities 131,719.00 16,445.00
Income Taxes Paid Refund Classified As Operating Activities 1,343,266.00 2,618,347.00
Cash Flows From Used In Operating Activities -10,174,684.00 -1,184,928.00
Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities 2,602,051.00 947,493.00
Purchase Of Property Plant And Equipment Classified As Investing Activities 11,914,452.00 17,189,638.00
Purchase Of Intangible Assets Classified As Investing Activities 2,432,233.00 1,442,566.00
Purchase Of Other Longterm Assets Classified As Investing Activities 33,623.00 0.00
Cash Flows From Used In Investing Activities -16,135,854.00 -12,334,687.00
Payments Of Lease Liabilities Classified As Financing Activities 9,625,895.00 10,392,128.00
Cash Flows From Used In Financing Activities -10,453,801.00 -24,468,340.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes -36,764,339.00 -37,987,955.00
Cash and cash equivalents 14,659,434.00 10,659,838.00

Please note that some sums might not add up.

Filings & Publications

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

ROIAFRACNOR4

LEI

2138004ATSD4SVFAZ789

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Bucharest Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.